Lenalidomide
Active Awarded Last action
- Contract number
- 36C24226N0564
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $3,130,958
Award facts
- Contract value 22% obligated
-
- $3,130,957.90 Current, with exercised options
- $14,104,814.58 Potential, with all options
- Completion date 13% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,206,298 | |
| Funding Only Action | -$149,673 | |
| Original award | $5,486,928 |
About this award
Veterans Integrated Service Network 2 issued a $14.1 million delivery order to Exelan Pharmaceuticals Inc. on June 1, 2026, for Lenalidomide oncology and hematologic malignancy treatments, with a ceiling value of $14,104,814.58 and ultimate completion date of May 31, 2029.
The order is placed under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Boca Raton, FL. Exelan Pharmaceuticals is a foreign-owned pharmaceutical manufacturer and distributor competing on an unrestricted, full-and-open basis with no set-aside designation. The company operates across a portfolio of single-award IDIQs and supply schedule contracts for specialty pharmaceuticals and bulk repackaging services to federal healthcare agencies. Exelan performs substantially all work at its primary Boca Raton facility and secondary locations in Cary, North Carolina; Summit, New Jersey; Ottawa, Ontario, Canada; and designated federal delivery points, operating exclusively as a prime contractor with no identified subcontractors.
Quick answers
Who was awarded contract 36C24226N0564?
36C24226N0564 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 2 (Veterans Health Administration) on June 1, 2026.
How much is contract 36C24226N0564 worth?
The government has obligated $3,130,958 on 36C24226N0564. Its potential value, with all options, is $14,104,815.
Is contract 36C24226N0564 an order under another contract?
Yes. 36C24226N0564 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24226N0564 competed?
The extent of competition for 36C24226N0564 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award